Recent data from the European Center for Disease Prevention and Control (ECDC) highlights that while hepatitis B prevalence among children under five has reached near-zero levels, only nine out of 25 EU/EEA countries have achieved the WHO target of 95% vaccination coverage against hepatitis B. Additionally, harm reduction strategies for hepatitis C remain insufficient, with only seven countries meeting the WHO standards for sterile injection equipment distribution. Approximately 5 million individuals in the EU/EEA are living with chronic hepatitis B or C, underscoring the urgent need for enhanced preventive actions.